度普利尤单抗阻断IL-4Rα降低特应性皮炎金黄色葡萄球菌定植并增加微生物多样性
该双盲安慰剂对照研究纳入54例中重度特应性皮炎患者,按1:1随机接受度普利尤单抗200 mg每周或安慰剂治疗16周,通过16S rRNA测序和qPCR分析皮损与非皮损皮肤菌群。结果显示度普利尤单抗治疗期间微生物多样性增加、金黄色葡萄球菌丰度下降,且菌群变化与临床改善及2型免疫生物标志物相关。
要点
- 度普利尤单抗治疗可增加AD患者皮肤微生物多样性并降低金黄色葡萄球菌丰度。
- 金黄色葡萄球菌丰度下降与AD临床改善及2型免疫生物标志物相关。
- 治疗前皮损皮肤较非皮损皮肤微生物多样性更低、金黄色葡萄球菌总丰度更高。
核心结论
- IL-4Rα抑制介导的AD临床改善及2型炎症抑制与皮肤微生物多样性增加和金黄色葡萄球菌丰度降低相关。
研究设计与样本
- 双盲、安慰剂对照研究,54例中重度AD患者按1:1随机接受度普利尤单抗200 mg每周或安慰剂治疗16周。
- 采集皮损与非皮损皮肤拭子,通过16S rRNA基因测序评估微生物多样性和葡萄球菌相对丰度,通过定量PCR测定金黄色葡萄球菌绝对丰度。
主要发现
- 治疗前皮损皮肤较非皮损皮肤微生物多样性更低、金黄色葡萄球菌总丰度更高。
- 度普利尤单抗治疗期间微生物多样性增加、金黄色葡萄球菌丰度下降,非皮损和皮损皮肤均可见明显变化。
- 度普利尤单抗治疗期间金黄色葡萄球菌丰度下降与AD临床改善及2型免疫生物标志物相关。
临床怎么用
- 度普利尤单抗治疗中重度AD时,皮肤菌群改善与临床获益同步,可作为理解疗效机制的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dupilumab is a fully human antibody to interleukin-4 receptor α that improves the signs and symptoms of moderate to severe atopic dermatitis (AD). To determine the effects of dupilumab on Staphylococcus aureus colonization and microbial diversity on the skin, bacterial DNA was analyzed from swabs collected from lesional and nonlesional skin in a double-blind, placebo-controlled study of 54 patients with moderate to severe AD randomized (1:1) and treated with either dupilumab (200 mg weekly) or placebo for 16 weeks. Microbial diversity and relative abundance of Staphylococcus were assessed by DNA sequencing of 16S ribosomal RNA, and absolute S. aureus abundance was measured by quantitative PCR. Before treatment, lesional skin had lower microbial diversity and higher overall abundance of S. aureus than nonlesional skin. During dupilumab treatment, microbial diversity increased and the abundance of S. aureus decreased. Pronounced changes were seen in nonlesional and lesional skin. Decreased S. aureus abundance during dupilumab treatment correlated with clinical improvement of AD and biomarkers of type 2 immunity. We conclude that clinical improvement of AD that is mediated by interleukin-4 receptor α inhibition and the subsequent suppression of type 2 inflammation is correlated with increased microbial diversity and reduced abundance of S. aureus.
引用
- Callewaert C, Nakatsuji T, Knight R, et al. IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis. J Invest Dermatol. 2019. PMID: 31252032. doi:10.1016/j.jid.2019.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。